Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07053917 · ClinicalTrials.gov registry record · Phase 1

Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability

A Phase 1 study of Stroke and Ischemic Stroke, sponsored by Johns Hopkins University.

Recruiting
Registry status
Phase 1
Development phase
20
Enrollment target
1
Study location

NCT07053917 is a Phase 1 study of Stroke and Ischemic Stroke that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 20 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07053917, a Phase 1 study of Stroke and Ischemic Stroke, is actively recruiting participants, sponsored by Johns Hopkins University.

RECRUITING
Registry status
Phase 1
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.

Conditions Studied

Stroke Ischemic Stroke Chronic Stroke Intracerebral Haemorrhage Hemiparesis After Stroke Intracerebral Haemorrhage (ICH) Intracerebral Hemorrhage Basal Ganglia Ischemic Stroke and Hemorrhagic Stroke Hemiplegia Following Ischemic Stroke Hemiplegia and Hemiparesis

Interventions

  • DRUG Psilocybin (Usona Institute)

Study Locations (1)

Maryland

  • Johns Hopkins - Baltimore

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2026-02-09
Est. Completion 2027-03
Phase Phase 1

Sponsor

Johns Hopkins University

1,448 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT07053917

The ClinicalTrials.gov registry entry for NCT07053917 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (100% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 10 conditions, with Stroke appearing as the primary indexed condition, and to 1 intervention - of which Psilocybin (Usona Institute) is the first listed.

NCT07053917 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT07053917 about?

NCT07053917 is a clinical study titled "Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability". The main purpose of the current studies is to evaluate the safety and tolerability of psilocybin in patients with chronic stroke.

What is the current status of trial NCT07053917?

This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2026-02-09. Estimated completion is 2027-03.

What conditions does trial NCT07053917 study?

This clinical trial studies the following conditions: Stroke, Ischemic Stroke, Chronic Stroke, Intracerebral Haemorrhage, Hemiparesis After Stroke.

What interventions are being tested in trial NCT07053917?

The interventions under investigation include: Psilocybin (Usona Institute) (DRUG).

Who is sponsoring clinical trial NCT07053917?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07053917 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Stroke

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Stroke

All registered trials for this condition

Ischemic Stroke

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.